Last reviewed · How we verify
NCT04278001: BLAST
Clinical Usefullness of the Cuffless SOMNOtouch NIBP Device for 24-hour Ambulatory Blood Pressure Measurement
NA trial testing Dual 24-hour ABPM in Arterial Hypertension in 60 participants. Completed in 1 February 2020.
1 February 2020
Quick facts
| Lead sponsor | Central Jutland Regional Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 60 |
| Start date | 1 September 2018 |
| Primary completion | 1 February 2020 |
| Estimated completion | 1 February 2020 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Dual 24-hour ABPM
Conditions studied
- Arterial Hypertension — all drugs for Arterial Hypertension →
Sponsor
Central Jutland Regional Hospital
Who can join
18 and older, any sex, with Arterial Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The SOMNOtouch NIBP is a cuffless device for continuous blood pressure measurement. The device is widely used, but validation for 24-hour ambulatory blood pressure measurement (ABPM) is limited. This study seeks to validate the SOMNOtouch device for use in 24-hour ABMP as compared to a validated oscillometric device for 24-hour ABPM. A total of 60 patients with indication for 24-hour BP measurement will be recruited from our tertiary hypertension Clinic. All included patients will conduct dual 24-hour ABPM with both the SOMNOtouch NIBP and a the oscillometric device. Furthermore, patients will undergo measurement of arterial stiffness with a Sphygmocor device as well as complete a questionaire on device related discomfort.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The cuffless SOMNOtouch NIBP device shows poor agreement with a validated oscillometric device during 24-h ambulatory blood pressure monitoring.
Nyvad J, Christensen KL, Buus NH, Reinhard M. · · 2021 · cited 19× · PMID 33350030 · DOI 10.1111/jch.14135
Verify or expand the search:
- PubMed search for NCT04278001
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arterial Hypertension
Currently open trials in the same condition.
- NCT06769269 — Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalizat · recruiting
- NCT07303556 — Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs · NA · active not recruiting
- NCT06828211 — Trans-resveratrol's Influence on the Development of CHF in Early Postmenopausal Women with HTN and Reduced BMD · NA · active not recruiting
- NCT07049289 — Telemonitoring in Arterial Hypertension · NA · active not recruiting
- NCT06722625 — Telemedical Algorithm-Supported Care for Hypertension · NA · recruiting
Other Central Jutland Regional Hospital trials
Trials by the same sponsor.
- NCT07278297 — Parkinson Ballroom Fitness: The Impact of Personalized Dance on Motor- and Nonmotor Symptoms in People With Parkinson's · NA · enrolling by invitation
- NCT06877078 — Effect of Pre-Surgery Constipation Podcast: A RCT · NA · recruiting
- NCT06246578 — Concordance of Hypoglycemia Measurement With Simultaneous Use of Two Devices for Continuous Glucose Measurement. · NA · suspended
- NCT06053138 — Assessment of BHB Concentration Agreement Among Sampling Locations and the Impact of Ketosis on EPO, and More · NA · completed
- NCT04686019 — More Air - Better Performance - Faster Recovery · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04278001 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central Jutland Regional Hospital
- Last refreshed: 2 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04278001.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing